European Companies Search Engine
UK funding (£827,800): An Enhanced Artificial Intelligence Breast MRI Scanning System (IntelliScan) Ukri 1 Feb 2018 UK Research and Innovation, United Kingdom
Overview
Text
An Enhanced Artificial Intelligence Breast MRI Scanning System (IntelliScan)
| Abstract | "Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015 (second most common cancer overall). This represents about 12% of all new cancer cases and 25% of all cancers in women. According to the World Health Organisation (Global Heath Estimates 2013), over 50% of breast cancer cases and 42% of deaths occur in developed countries. This includes the UK, where one in 5 cases of breast cancer results in a fatality. This project therefore seeks to develop INTELLISCAN, an Artificial Intelligence, machine learning enhanced breast MRI scanning system for use as a highly efficient, more accurate breast cancer screening tool. Our technology applies computer based image processing to deliver improved, instant, automated anomaly detection of breast MRI scans. " |
| Category | Collaborative R&D |
| Reference | 104192 |
| Status | Closed |
| Funded period start | 01/02/2018 |
| Funded period end | 31/01/2021 |
| Funded value | £827,800.00 |
| Source | https://gtr.ukri.org/projects?ref=104192 |
Participating Organisations
| FIRST OPTION SOFTWARE LIMITED |
£193,444.00 |
| BRUNEL UNIVERSITY LONDON |
£329,874.00 |
| TEESSIDE UNIVERSITY |
£304,482.00 |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: First Option Software Ltd., Alresford.